Grants and Contributions:
Title:
Expansion of a novel CAR approach into solid tumors
Agreement Number:
1011862
Agreement Value:
$600,000.00
Agreement Date:
Sep 28, 2023 - Mar 31, 2026
Description:
The project, focuses on confirming the baseline value proposition of a novel receptor scaffold technology by showcasing superior features of the firm's T-cell product compared to standard of care in vivo. The technology will then be expanded to build a treatment directed towards solid tumours.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H2S 2R8
Reference Number:
172-2023-2024-Q3-1011862
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
711826271
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 186 days. The total amended value is 130,000 dollars.
Amendment Date
Sep 10, 2025
Recipient's Operating Name:
Modulari-T
Recipient's Legal Name:
12343096 CANADA INC.
Federal Riding Name:
Rosemont--La Petite-Patrie
Federal Riding Number:
24064
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: